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Abstract 
Background: sIgE and sIgG4 detection is necessary for more accurate and effective type I hypersensitivity diagnos-
tics and the estimation of disease development. Typically, the analyses of these antibodies are performed separately 
with the help of various specialized systems. The aim of this study was to develop a microarray-based method for the 
simultaneous quantitative detection of sIgE and sIgG4 to the most common allergens in a single sample.
Methods: A quantitative method for the simultaneous detection of sIgE and sIgG4 was developed based on the 
technology of hydrogel microchips previously designed at Engelhardt Institute of Molecular Biology, Russian Acad-
emy of Sciences (EIMB RAS). The microarray contained gel pads with immobilized allergens and gel pads that allow 
for the obtaining of sIgE and sIgG4 internal calibration curves for each allergen during the assay. The possibility of the 
simultaneous detection of sIgE and sIgG4 was developed using the corresponding Cy5 and Cy3 fluorescent dyes.
Results: The multiplex immunoassay method using hydrogel microarrays developed in this study allowed the 
quantitative detection of sIgE and sIgG4 to 31 allergens from different groups in a single assay. A comparison of the 
microarray with the existing plate-based analogues (i.e., ALLERG-O-LIQ and sIgG4 ELISA) was performed by analysing 
152 blood serum samples and by evaluating Pearson correlation coefficients, ROC analysis, and Passing-Bablok linear 
regression results.
Conclusion: The implementation of this method in allergy diagnostics will provide the possibility of simultaneously 
performing primary patient screening and obtaining additional information concerning the severity of the allergies 
and the choice of an appropriate therapy.
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Background
The incidence of allergic diseases steadily increases 
year after year. One or more allergic signs are detected 
in 30–40% of the world population, and the number of 
patients suffering from immunoglobulin-related food 
intolerance (so-called food allergies) has reached 240–
550 million people [1].
According to the classification of Coombs and 
Gell [2], IgE is assumed to be a key marker of type I 
hypersensitivity for in vitro diagnostics. Fc region of IgE 
coupled with allergen has the ability to bind to FcεRI 
receptor on the basophils and mast cells membranes, that 
elicits their subsequent activation. This process explains 
the rapid effects of allergen-sIgE complexes in the forma-
tions of allergic rhinitis, asthma, urticaria and anaphylac-
tic reactions [3].
However, the presence of sIgE in the blood is not an 
absolute marker for the presence of clinical manifesta-
tions of immunological failure [4]. In certain cases, the 
manifestation of allergy symptoms can be suppressed 
by the presence of immunoglobulin G, which acts as a 
“blocking antibody”. Typically, such blocking properties 
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are distinctive hallmarks of the IgG4 antibody subclass 
[5]. According to the number of studies sIgG4 level as 
well as the ratio sIgE/sIgG4 is associated with likelihood 
of allergic symptoms reporting [6, 7] and can improve 
the prediction of tolerance to some allergens [8]. There-
fore, sIgG4 detection together with sIgE measurement 
gives more inclusive information for in  vitro analysis 
interpretation.
The sIgG4 level is also used to monitor allergen-specific 
immunotherapy (SIT) because successful therapy is char-
acterized by an increase in sIgG4 and a decrease in sIgE 
[5, 9]. Thus, patient management strategy, particularly 
the selection of appropriate drugs for SIT, depends not 
only on the early recognition of the allergens that cause 
hypersensitivity but also on the monitoring of sIgE and 
sIgG4 levels [10]. Currently, determination of sIgE in 
clinical lab is generally performed by numerous single-
plex and multiplex tests [11]. Amongst the most useful 
tools for multiplex sIgE determination are microarrays 
[12], which allow for the identification of a plurality of 
analytes during a single analysis of a blood serum sample.
Test systems for the determination of sIgG4 levels in 
the serum are less widespread. Given that the IgG4 serum 
concentration on average is greater than the IgE con-
centration, these tests often require an additional sam-
ple preparation stage, i.e., the pre-dilution of the serum 
prior to analysis. Consequently, the handling of two sepa-
rate tests is required for the parallel detection of sIgE 
and sIgG4 in the same serum sample. This requirement 
complicates the diagnoses of patients with suspected 
allergies. To solve this problem, an microarray approach 
based on developing antibodies that are specific to cer-
tain classes of immunoglobulins and labelled with vari-
ous dyes was proposed [13]. The main advantage of this 
approach is the ability to multiply the number of defined 
parameters within a single analysis. In comparison with 
conventional ELISA microarray format allows to detect 
sIgE and sIgG4 to the number of allergens, including 
those sensibilization to which was not suspected and was 
not exhibited because of the blocking antibodies. Fur-
thermore such testing with microarrays requires appreci-
ably less amount of biomaterial.
The study conducted by Rubina et  al. in cooperation 
with Fooke-Achterrath [14] demonstrated the possibility 
of simultaneous sIgE and sIgG4 detection using hydrogel 
biochips. As a result of this approach, in this paper we 
have developed a method for the simultaneous quantita-
tive analysis of allergen-specific immunoglobulins E and 
G4 to 31 allergens belonging to different groups. The cur-
rent study presents the analytical characteristics of the 
developed method and comparison to the established 
reference methods after assay of serum samples from 
patients and healthy donors.
Methods
Samples
In our research, we included surplus blood serum sam-
ples that remained after routine diagnostic procedures. 
The samples were obtained from healthy donors (control 
group) and patients who were referred for sIgE determi-
nation by allergologists/pulmonologists for the diagno-
sis and monitoring of the following disease states: atopic 
dermatitis, asthma, urticaria, and rhinitis. The object of 
our research was an age-diverse group (5–65  years old) 
from the Moscow population.
In total, 152 serum samples were analysed in this study. 
Among these, 82 samples were from adult patients with 
suspected allergic diseases, and 15 samples were from 
healthy donors; these samples were provided by the Fed-
eral State Budgetary Institution Polyclinic No. 1 of the 
Business Administration for the President of the Russian 
Federation. Additionally, 45 sera samples from children 
with suspected allergic diseases and 10 sera samples from 
healthy children who did not have allergies were pro-
vided by the Filatov Moscow City Pediatric Clinic No. 13.
The conditions of blood sampling, the delivery, and 
storage of the samples were identical. The blood for 
serum isolation was collected via a puncture of the 
median cubital vein, the serum was separated from the 
blood corpuscles by centrifugation (3000  rpm, 10  min) 
within the first 2 h after blood sampling. All of the sam-
ples were exposed to a single refrigeration at −45  °C. 
Samples were delivered in insulated containers with ice 
packs.
Design and manufacture of the microarrays
Table 1 provides a list of the allergens (GREER, USA) that 
were immobilized in the microarray gel pads. The micro-
array contained elements with allergens belonging to the 
main groups, i.e., pollen, household, epidermal, food, 
fungi, and insect venoms.
Microarray  manufacture was performed according to 
the method developed at Engelhardt Institute of Molec-
ular Biology, Russian Academy of Sciences (EIMB RAS) 
[15, 16]. For this purpose, glass slides (Menzel-Glaser, 
Germany) treated with Bind Silane (Amersham Phar-
macia Biosciences, USA) were used. The microarray gel 
pad arrangement is illustrated in Fig. 1. The gel pads con-
tained allergens or mixtures of IgE and IgG4 antibodies at 
certain concentrations for the internal calibration curve 
construction (rows 34–45). Immobilized on the glass 
slide, the proteins were evenly distributed throughout the 
entire volume (0.1 nl) of each semispherical gel element 
of approximately 80 microns in diameter. Each probe was 
immobilized in four repeats to improve the reproducibil-
ity of the analysis. Figure 2 provides example microarray 
images after the performance of the immunoassay.
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Preparation of the dye‑conjugated antibodies
Two microliters of Cy5 or Cy3  N-hydroxysuccinimide 
ester solution (GE Healthcare, UK) (2 mg/ml in dimeth-
ylformamide) were added to 75  µl of anti-IgE (Bethyl, 
USA) or anti-IgG4 (Fitzgerald, USA) antibody solution 
(1 mg/ml in 0.01 M bicarbonate buffer, pH 9.5). The reac-
tion was performed at 22 °C for 1 h in the dark with stir-
ring (550  rpm). Purification of the antibody conjugate 
from the unreacted dye (Cy5 or Cy3) was performed by 
gel filtration on a Micro Bio-Spin column (Bio-Rad, USA) 
filled with Sephadex G-25 Coarse (Sigma, USA) and 
equilibrated with PBS (0.01 M phosphate buffer, pH 7.2, 
0.15 M NaCl) buffer. The dye/protein molar ratio of the 
final conjugates was determined spectrophotometrically 
to be 3.
Analysis of sIgE and sIgG4 on the microarrays
Each microarray was incubated with sixty-five micro-
liters of blood serum at 37  °C for 20  h. After wash-
ing in PBST (PBS, 0.1% Tween-20 (Sigma, USA)) for 
20  min, 50  µl of developing solution containing anti-
IgE-Cy5 and/or anti-IgG4-Cy3 (working concentrations 
of 2.5 and 1.5  µg/ml, respectively) was applied to the 
microarray, and the microarray was incubated at 37 °C 
for 1  h in the dark. After a final washing in PBST for 
30 min, the registration of the fluorescence signals was 
performed.
Measurement of the fluorescence intensities of the 
microarray gel pads
The registration of fluorescence signals was performed 
using a two-wavelength microarray analyser (EIMB RAS) 
based on the concept of digital wide-field fluorescence 
microscopy. While working with the fluorescent dyes, 
excitation was provided by laser diodes that emitted light 
at 532 nm (Cy3) or 655 nm (Cy5). The fluorescence inten-
sities of the gel elements were registered by a CCD cam-
era using interference filters of 607 ± 35 nm for Cy3 and 
716 ± 22 nm for Cy5. The analyser operation, the analyses 
of the fluorescent images and the calculations of the sIgE 
and sIgG4 concentrations were performed with ImageAs-
say software (EIMB RAS). A standard method of the gel 
element fluorescence calculation that has been previously 
described [17] was employed. The final fluorescence of 
each data point was calculated as the median value of the 
four fluorescence signals obtained from the repeats.
Table 1 List of gel pads in the microarray
a Purified allergen components
Allergens
1 Alder 16 Dermatophagoides pteronyssinus
2 Birch 17 Dermatophagoides farinae
3 Hazelnut 18 Alternaria tenius
4 Oak 19 Egg white
5 Wormwood 20 Cow milk
6 Mugwort 21 α-lactalbumin, cow milka
7 Dandelion 22 β-lactoglobulin, cow milka
8 Bermuda grass 23 Casein, cow milka
9 Orchard grass 24 Codfish
10 Meadow fescue 25 Wheat flour
11 Perennial rye grass 26 Peanut
12 Timothy grass 27 Hazelnut
13 Cultivated rye 28 Carrot
14 Cat dander 29 Apple
15 Dog dander 30 Peach
31 Cockroach, German
Controlling gel pads
32 Anti-human IgE and anti-human IgG4 antibodies
33 Empty gel pads
34–45 IgE + IgG4 (internal calibration curve)
M Marker gel pads
Page 4 of 13Feyzkhanova et al. Clin Proteom  (2017) 14:1 
Processing and interpretation of the results
The concentrations of antibodies that were immobi-
lized in the microarray gel pads 34–45 (Fig.  1) were 
chosen and arranged in ascending order so that after 
analysing the fluorescent signals from rows 34–45, 
the entire ranges of the signal intensities for sIgE (up 
to 100  IU/ml) and sIgG4 (up to 2500  ng/ml) were 
covered.
Fig. 1 Design of the microarray for the simultaneous detection of sIgE and sIgG4 to 31 allergens. The numbers in the circles correspond to the 
allergen numbers in Table 1
Fig. 2 Example microarray fluorescent images after analysis. The images were made after the incubation of the microarray with the serum sample, 
and development of the fluorescent-labelled anti-human antibodies, anti-IgE-Cy5 and anti-IgG4-Cy3, was achieved via laser excitations at 655 nm 
(Cy5, a) and 532 nm (Cy3, b)
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Each manufactured lot of microarrays was calibrated 
using characterized standard blood sera-based samples 
including a zero sample (PBS, 0.1% PVA, and 0.1% PVP). 
For each allergen, the sIgE and sIgG4 concentrations of 
the standard samples were ascribed to the relative fluo-
rescence intensity of each gel pad that was used for cali-
bration curve plotting.
Treatment with a mixture of fluorescently labelled 
conjugates of anti-IgE-Cy5 and anti-IgG4-Cy3 resulted 
in the formation of binary complexes with correspond-
ing conjugates in the gel pads 34–45. According to the 
fluorescent signals from these gel pads and the attrib-
uted concentrations of sIgE and sIgG4, internal calibra-
tion curves were constructed for each of the allergens. 
The determinations of the sIgE and sIgG4 concentrations 
were performed according to the fluorescent signals from 
the gel pads with the immobilized allergens in relation to 
the internal calibration curves.
Analysis of IgE and IgG4 using reference methods
The analyses of the serum samples were performed using 
the Specific IgE REAST (ALLERG-O-LIQ) and Specific 
IgG4 ELISA (Dr. Fooke Laboratorien GmbH, Germany) 
test systems according to the procedures described in the 
manufacturer’s instructions. Data processing was per-
formed with the ALLERG-O-Win software (Dr. Fooke 
Laboratorien, GmbH).
Determination of the analytical characteristics
Dilution test
The linearity of the method was evaluated via the analy-
sis of blood serum samples that had been diluted 2, 4, 8, 
and 16 times. The dilutions were performed with the zero 
sample.
Detection limit
The detection limits for sIgE and sIgG4 were determined 
via serial dilutions of two samples that contained signifi-
cant amounts of sIgE to pollen (grey alder, birch, meadow 
fescue, timothy grass), cat dander, and cow milk and 
sIgG4 to cat dander, dog dander, cow milk, wheat, pea-
nut, and hazelnut. The detection limit for each allergen 
was established as the concentration associated with 
the fluorescence value that was two standard deviations 
larger than the average value of the tenfold measured flu-
orescent signal of the zero sample.
Within‑run precision
The evaluation of the within-run precision of the method 
was performed via an analysis of blood serum samples 
containing sIgEs and sIgG4s to various allergens. The 
assay was performed using 10 repeats for each sample. 
The samples were chosen such that the concentrations of 
sIgE and sIgG4 covered the entire dynamic ranges of the 
measurements.
Comparison with other methods: correlation and regression 
analysis
For a number of allergens, the Pearson correlation coeffi-
cients r [18] of the concentrations obtained by the micro-
array and commercial test systems were determined. 
Passing–Bablok regression analyses [19], ROC curve anal-
ysis, sensitivity and specificity were also performed using 
the MedCalc program, version 16.4.3. The parameters of 
the regression line were determined as (Y = A + B × X), 
where the intercept is A, the slope is B, and the associated 
95% confidence intervals were calculated.
Results and discussion
Design of the microarray and analysis procedure
The three-dimensional hydrogel microarray produced at 
EIMB RAS was used as an analytical instrument for the 
development of a multiplex simultaneous quantitative 
assay of sIgEs and sIgG4s for 31 allergens in blood serum 
samples.
The microarray structure and lists of the immobilized 
allergen extracts and purified components are provided 
in Fig. 1 and Table 1. The allergens were chosen with con-
sideration of the frequencies of allergen reactions in Cen-
tral Russia, which mainly corresponds to the frequencies 
in Central and Northern Europe [20]. The allergens 
belonged to different groups that included pollen, indoor 
allergens and food allergens.
In addition to allergens, the structure of the microarray 
was enlarged with gel pads with immobilized immuno-
globulins E and G4, which were used to plot an internal 
calibration curve (after development with Cy5- and Cy3-
labeled anti-human antibodies). The internal calibration 
curve was used to control for the development system 
activity during the assay.
Mutual influence of Cy3‑ and Cy5‑labeled antibodies 
on the developing system
To control the validity of the developing system that 
contained mixtures of antibodies labelled with different 
fluorescent dyes, an analysis of the serum samples was 
performed using three variations of developing solutions: 
anti-IgE-Cy5, anti-IgG4-Cy3, and a mixture of anti-IgE-
Cy5 and anti-IgG4-Cy3. The fluorescent signals obtained 
after the analysis are illustrated in Fig. 3. The differences 
in the signals of the individually labelled antibodies and 
their mixture fit within the standard deviation of the 
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Fig. 3 Fluorescent signals obtained using different developing systems for two different samples (a and b). The fluorescence of Cy5 for sIgE 
(green columns: developed with anti-IgE-Cy5 individually; red columns: developed with an anti-IgE-Cy5/anti-IgG4-Cy3 mixture) was registered at 
716 ± 22 nm, and the fluorescence of Cy3 for sIgG4 (yellow columns: developed with an anti-IgE-Cy5/anti-IgG4-Cy3 mixture; blue columns: devel-
oped with anti-IgG4-Cy3 individually) was registered at 607 ± 35 nm
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analysis of the hydrogel microarrays, which indicates the 
propriety of the selected developing system.
Analytical characteristics of the method
The accuracy of the developed method was evaluated 
via an estimation of analytical characteristics includ-
ing the dilution linearity, detection limit and within-run 
precision.
Dilution linearity
This test was performed via the serial dilution of a sample 
with a high analyte concentration and follow-up compar-
isons of the experimental concentrations with the esti-
mated concentrations.
A blood serum sample containing 14.58 IU/ml sIgE to 
birch pollen, 6.49 IU/ml sIgE to meadow fescue, 1205 ng/
ml sIgG4 to cow milk and 373 ng/ml sIgG4 to peanut was 
diluted 2, 4, 8, and 16 times with the zero sample. Fig-
ure 4a, c illustrate the decreasing concentration-dilution 
curves for the sIgE and sIgG4 measurements, respec-
tively. The dashed line depicts the corresponding curves 
for the expected concentrations. The experimental/
expected concentration ratios for the different dilutions 
are provided in Fig. 4b, d for sIgE and sIgG4, respectively.
As illustrated in the figures, the experimentally deter-
mined sIgE concentrations differed from the calculated 
concentration by no more than ±10%. The experimental/
expected concentration ratios for sIgG4 were also in the 
Fig. 4 Results of the serum sample dilution analysis. a The concentration-dilution curve for the measured (solid lines) and expected (dashed lines) 
concentrations of sIgE to birch pollen (circles) and meadow fescue pollen (triangles). b The experimental/expected concentration ratios of sIgE to 
the allergens listed above. c The concentration-dilution curves for the measured (solid lines) and expected (dashed lines) concentrations of sIgG4 to 
cow milk (diamonds) and peanut (squares). d The experimental/expected concentration ratios of sIgG4 to the allergens listed above
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range of 0.9–1.1. The presence of the regular pattern dur-
ing the serum dilution indicates the absence of a matrix 
effect, i.e., a lack of interference from different serum 
components. Consequently, the mean per cent linearities 
for both sIgE and sIgG4 for the serum were in the range 
of 90–110%, which meets with the requirements for 
immunoassay methods.
Detection limit
The detection limits were determined via serial dilution 
of the serum samples. For example, the reliable detected 
concentrations for the serum sample with sIgE concen-
trations to meadow fescue (15.14  IU/ml), timothy grass 
(11.11  IU/ml), cat dander (3.36  IU/ml), and cow milk 
(2.38  IU/ml) were 0.24  IU/ml, 0.17  IU/ml, 0.21  IU/ml, 
and 0.15 IU/ml, respectively. The same sample contained 
708 ng/ml sIgG4 to cat dander and 432 ng/ml sIgG4 to 
peanut. The reliable sIgG4 concentrations after dilution 
were 11 and 14 ng/ml, respectively.
For all allergens, the limit of sIgE detection did not 
exceed 0.25 IU/ml. This value is above the detection limit 
of the existing methods (0.1 IU/ml for ImmunoCAP and 
Immulite) but still below the internationally accepted 
cut-off concentration for allergodiagnostics (0.35 IU/ml). 
The detection limit for the sIgG4 concentration did not 
exceed 100 ng/ml.
Within‑run precision
Table  2 provides the average concentrations that were 
determined in the assay of the 2 serum samples in 10 rep-
etitions and the calculated coefficients of variation for the 
different allergens. As shown in the table, the within-run 
precision did not exceed 15% for sIgE or 17% for sIgG4 
determinations in the measured concentration range.
The results of the comparison between the hydrogel 
microarrays and ELISA
The serum samples (n = 127) were obtained from atopic 
patients from 2 age groups, i.e., age 0.5–17 years (n = 45) 
and age 18–74  years (n  =  82). Figure  5 illustrates the 
distribution of increased (≥0.35  IU/ml) sIgE concentra-
tions for different allergens for the patients based on the 
experimental data. For the comparative evaluation of the 
multiplex simultaneous sIgE and sIgG4 immunoassay on 
the hydrogel microarrays, analyses of 152 serum samples 
(127 atopic patients and 25 healthy donors) for different 
allergens were performed with both the microarrays and 
the reference methods for the sIgE (ALLERG-O-LIQ) 
and sIgG4 (sIgG4 ELISA) determinations. For each aller-
gen, no fewer than 10 serum samples were analysed using 
ALLERG-O-LIQ and an sIgG4 ELISA.
Scatter diagrams of the results obtained from the anal-
yses of sIgE concentrations to birch pollen, mugwort pol-
len, timothy grass pollen, and dog dander on the hydrogel 
microarrays and ALLERG-O-LIQ are provided in Fig. 6. 
The scatter diagrams of the results for the sIgG4 con-
centrations to dog dander, cow milk, wheat flour, and 
hazelnut in the samples as measured on the hydrogel 
microarrays and the sIgG4 ELISA are provided in Fig. 7.
Pearson’s correlation coefficients r and the sample sizes 
n for the analysed allergens are provided in Table 3. For 
the remaining allergens, sufficient sample sizes were not 
obtained for the determination of correlation coefficients 
with p < 0.01.
Table 2 Results of the within-run precision test
The average sIgE and sIgG4 concentrations were obtained in a simultaneous immunoassay of the microarrays, and the corresponding coefficients of variation for the 2 
serum samples analysed in 10 repetitions are provided
sIgE analysis sIgG4 analysis
Sample Allergen Average sIgE  
concentration, IU/ml
CV, % Sample Allergen Average sIgG4  
concentration, ng/ml
CV, %
#1 Cat dander 0.76 5.7 #1 Hazelnut 112 7.9
#1 Timothy grass 2.77 7.6 #1 Cow milk 529 11.3
#1 Mugwort 32.4 11.5 #1 Wheat 926 15.6
#1 House dust mite  
(D. pteronyssinus)
59.7 14.5 #1 Egg 2165 16.8
#2 Cat dander 0.57 6.7 #1 Hazelnut 108 7.6
#2 Timothy grass 1.56 9.5 #2 Wormwood 27.5 10.1
#2 Mugwort 70.06 13.7 #2 Peanut 74.8 8.4
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The correlation coefficients observed in the compari-
sons between the microarray and reference methods for 
the different allergens were in the ranges of 0.68–0.93 
for the sIgE analyses and 0.67–0.96 for the sIgG4 analy-
ses. The obtained values are similar to the values of the 
correlation coefficients that have been calculated in com-
parisons of immunoassay methods in other works (for 
example, r =  0.525–0.979 in [21] and r =  0.60–0.98 in 
[22]). For some allergens the significant dispersion of the 
results led to the small correlation coefficients. This fact 
can be explained by the distinct component compounds 
of the protein allergen extracts produced by numerous 
manufacturers, by the variety of protein modifications 
that occur during the immobilization process, as well as 
the wide range of developing anti-human antibodies that 
can interact with sIgE populations with different effica-
cies [23].
Passing-Bablok regression analyses yielded the inter-
cept A and slope B for each allergen. The values are 
presented in Table 3. For all except two cases (sIgG4 to 
egg white and sIgE to dog dander), the 95% confidence 
intervals for the intercept included 0, and for all cases, 
the 95% confidence intervals for the slope included 1.
ROC analysis for sIgE detection was performed with 
the data differentiated through the common sIgE cut-off 
of 0.35  IU/ml (with disease: ≥0.35  IU/ml sIgE with the 
reference method; without disease:  <0.35 IU/ml sIgE 
with the reference method). The optimum cut-off for 
the described microarray-based method as defined by 
the Youden’s  J statistic-associated criterion was 0.52 IU/
ml. For this cut-off the sensitivity was 87.6%, the specific-
ity was 90.6%, and the diagnostic accuracy was 87%. The 
area under the curve (AUC) was 0.931 that corresponded 
to high accuracy test [24]. In general, the results observed 
following the application of different immunoassay meth-
ods cannot be inter-convertible because of significant 
differences that inevitably appear during clinical sample 
assays [25, 26]; however, in our case, it may be said that 
Fig. 5 Percentage increases in sIgE concentrations (≥0.35 IU/ml) to the different allergens. The results were obtained after analyses of serum sam-
ples from children (green columns) and adults (red columns) with the hydrogel microarrays
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for these concretely analysed allergens, there is no over-
estimation or underestimation of the sIgE and sIgG4 
measurements compared to the employed reference 
methods, i.e., ALLERG-O-LIQ and sIgG4 ELISA.
Conclusion
A microarray for the multiplex quantification of the 
concentrations of sIgE and sIgG4 to 31 allergens from 
different groups in serum samples was developed. The 
Fig. 6 Scatter diagrams of the comparisons of the hydrogel microarray with ALLERG-O-LIQ. Results for the sIgE determinations to the following 
allergens: a birch pollen, b mugwort pollen, c timothy grass pollen, and d dog dander
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simultaneous detection of sIgE and sIgG4 was made 
possible via the use of a developing system with two 
fluorescent dyes. This method allows for the obtain-
ing of sIgE and sIgG4 levels in common units without 
the construction of an external calibration curve. The 
analytical characteristics of the method satisfy the 
requirements that are applicable to immunofluorescent 
test systems.
The usage of this method in allergy diagnostics pro-
vides the possibility of both performing primary patient 
Fig. 7 Scatter diagrams for the comparisons of the hydrogel microarray with the sIgG4 ELISA. Results for the sIgG4 determinations to the following 
allergens: a dog dander, b cow milk, c wheat flour, and d hazelnut (food)
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screening and obtaining the additional information that 
is necessary for allergy severity evaluation and therapy 
selection.
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